Key result
Deep learning combined with differential expression analysis outperforms traditional machine learning for AMI classification.
Why the study?
Classifying diseases using gene expression data relies on selecting important genes, but traditional machine learning often uses simple feature selection techniques that can limit accuracy.
Does combining deep learning with differential expression analysis improve the classification of acute myocardial infarction patients using gene expression data compared to traditional machine learning?
Does combining deep learning with differential expression analysis improve the classification of acute myocardial infarction patients using gene expression data compared to traditional machine learning?
Combining deep learning with differential expression analysis improves the classification of acute myocardial infarction patients from gene expression data, aiding in biomarker identification.
Answers are grounded in this paper and cite their sources.
Supports DL-DEA integration for AMI gene classification; hypothesis-generating and requires prospective validation before clinical use.
BACKGROUND AND MOTIVATION Classifying diseases like heart problems using gene expression data depends on selecting important genes. Traditional machine learning (ML) often uses simple feature selection (FS) techniques, which can limit accuracy. In our research, we combine deep learning (DL) with gene-focused methods like differential expression analysis (DEA) to improve classification performance significantly. METHOD We thoroughly and rigorously evaluated ML and DL classifiers using two gene expression datasets (GSE36961 and GSE57345). We tested four hypotheses using feature selection methods such as chi-square, DEA. We applied principal component analysis (PCA) to reduce the number of features. To ensure the reliability of our findings, we applied k-fold cross-validation, hyperparameter tuning, block effect analysis, and assessed data augmentation and generalization. Statistical tests, including paired t-test and Mann-Whitney U test, and Wilcoxon signed-rank test were performed to compare model performances rigorously. RESULTS Our experiments on two gene expression datasets (GSE36961, GSE57345) not only confirmed all four hypotheses (H1, H2, H3, and H4) but also revealed significant performance improvements. For H1, without FS, DL outperformed ML models by a substantial margin. For H2, with FS, DL outperformed ML models by a significant percentage. In H3, ML with FS improved over ML without FS by a considerable margin. For H4, DL with FS outperformed DL without FS by a noticeable percentage. Among FS methods, DEA consistently yielded the best results for both ML and DL, further underlining the significance of our findings. CONCLUSIONS Combining DL with biological feature selection, especially DEA, improves gene expression classification and enables gene ranking and biomarker identification. This integrative approach balances modeling power with biological relevance, providing a reproducible framework for robust biomarker-based classification.
No takes yet. Share an insight, caveat, or question.
Chaudhary et al. (2026) studied Acute myocardial infarction. Deep learning with differential expression analysis (DEA) vs. Traditional machine learning models was evaluated on Classification performance. Deep learning combined with differential expression analysis significantly outperformed traditional machine learning models for the classification of acute myocardial infarction using gene expression data.
Synapse has enriched 10 related papers. Consider them for comparative context: